These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3038095)
1. Decreased level of calpain inhibitor activity in kidney from Milan hypertensive rats. Pontremoli S; Melloni E; Salamino F; Sparatore B; Viotti P; Michetti M; Duzzi L; Bianchi G Biochem Biophys Res Commun; 1987 Jun; 145(3):1287-94. PubMed ID: 3038095 [TBL] [Abstract][Full Text] [Related]
2. Decreased level of calpain inhibitor activity in red blood cells from Milan hypertensive rats. Pontremoli S; Melloni E; Salamino F; Sparatore B; Viotti P; Michetti M; Duzzi L; Bianchi G Biochem Biophys Res Commun; 1986 Aug; 138(3):1370-5. PubMed ID: 3019342 [TBL] [Abstract][Full Text] [Related]
3. Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase C. Pontremoli S; Melloni E; Damiani G; Salamino F; Sparatore B; Michetti M; Horecker BL J Biol Chem; 1988 Feb; 263(4):1915-9. PubMed ID: 2828358 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the Ca2+-dependent neutral proteinases from rabbit liver by an endogenous inhibitor. Melloni E; Salamino F; Sparatore B; Michetti M; Pontremoli S; Horecker BL Arch Biochem Biophys; 1984 Aug; 232(2):513-9. PubMed ID: 6087730 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the defective calpain-endogenous calpain inhibitor system in erythrocytes from Milan hypertensive rats. Pontremoli S; Melloni E; Salamino F; Sparatore B; Michetti M; Sacco O; Bianchi G Biochem Biophys Res Commun; 1986 Aug; 139(1):341-7. PubMed ID: 3021128 [TBL] [Abstract][Full Text] [Related]
7. Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation. Di Lisa F; De Tullio R; Salamino F; Barbato R; Melloni E; Siliprandi N; Schiaffino S; Pontremoli S Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):57-61. PubMed ID: 7755588 [TBL] [Abstract][Full Text] [Related]
8. Regional differences in ribonuclease content of rat and mouse kidney. Liu DK; Matrisian PE Biochem J; 1977 May; 164(2):371-7. PubMed ID: 880244 [TBL] [Abstract][Full Text] [Related]
9. Association between plasma membrane (Ca+Mg) ATPase and calpain/calpastatin system in rat erythrocytes. Soldati L; Vezzoli G; Salardi S; Spaventa R; Barber BR; Azzani T; Bianchi G Biochem Biophys Res Commun; 1996 May; 222(2):572-5. PubMed ID: 8670246 [TBL] [Abstract][Full Text] [Related]
10. A genetic deficiency in calpastatin and isovalerylcarnitine treatment is associated with enhanced hippocampal long-term potentiation. Muller D; Molinari I; Soldati L; Bianchi G Synapse; 1995 Jan; 19(1):37-45. PubMed ID: 7709342 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase activity in renal cortex and medulla of normotensive and spontaneously hypertensive rats. Nava E; LlinĂ¡s MT; Gonzalez JD; Salazar FJ Am J Hypertens; 1996 Dec; 9(12 Pt 1):1236-9. PubMed ID: 8972897 [TBL] [Abstract][Full Text] [Related]
12. Increased activity and expression of Ca(2+)-dependent NOS in renal cortex of ANG II-infused hypertensive rats. Chin SY; Pandey KN; Shi SJ; Kobori H; Moreno C; Navar LG Am J Physiol; 1999 Nov; 277(5):F797-804. PubMed ID: 10564245 [TBL] [Abstract][Full Text] [Related]
13. [Na, K-ATPase activity in the erythrocyte membrane preparations and kidneys of spontaneously hypertensive rats]. Kazennov AM; Maslova MN Fiziol Zh Im I M Sechenova; 1993 Aug; 79(8):66-72. PubMed ID: 8252103 [TBL] [Abstract][Full Text] [Related]
14. Altered renal expression of nitric oxide synthase isozymes in spontaneously hypertensive rats. Kim SW; Moon KH; Lee SC; Kim NH; Kang DG; Lee JU; Choi KC; Kang YJ Korean J Intern Med; 1999 Jan; 14(1):21-6. PubMed ID: 10063310 [TBL] [Abstract][Full Text] [Related]
15. Kidney kallikrein and phospholipase activities in Milan spontaneously hypertensive rats. Baggio B; Favaro S; Piccoli A; Borsatti A Prostaglandins; 1979 Jul; 18(1):83-92. PubMed ID: 523675 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. Pontremoli S; Salamino F; Sparatore B; De Tullio R; Pontremoli R; Melloni E Biochem Biophys Res Commun; 1988 Dec; 157(3):867-74. PubMed ID: 2849943 [TBL] [Abstract][Full Text] [Related]
17. Regulation of calpain activity in rat brain with altered Ca2+ homeostasis. Averna M; Stifanese R; De Tullio R; Passalacqua M; Defranchi E; Salamino F; Melloni E; Pontremoli S J Biol Chem; 2007 Jan; 282(4):2656-65. PubMed ID: 17135258 [TBL] [Abstract][Full Text] [Related]
18. Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes. Pontremoli S; Melloni E; Sparatore B; Salamino F; Michetti M; Sacco O; Horecker BL Biochem Biophys Res Commun; 1985 Jun; 129(2):389-95. PubMed ID: 2990453 [TBL] [Abstract][Full Text] [Related]
19. Changes in contents of calpain and calpastatin in rat liver during growth. Tanaka K; Harioka T; Murachi T Physiol Chem Phys Med NMR; 1985; 17(4):357-63. PubMed ID: 3014576 [TBL] [Abstract][Full Text] [Related]
20. Calpastatin level in spontaneously hypertensive rats. Soldati L; Molinari I; Salardi S; Barber BR; Ruggiero M; Serra F; Bianchi G Biochem Biophys Res Commun; 1991 Mar; 175(2):486-91. PubMed ID: 2018496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]